Clinical Trial: Metadoxine as a Therapy for Severe Alcoholic Hepatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Impact of Metadoxine in the Oxidative Stress and Early Mortality in Patients With Severe Alcoholic Hepatitis

Brief Summary: The purpose of this study is to determine whether metadoxine is effective for improve survival and reduced oxidative stress in patients with severe alcoholic hepatitis.

Detailed Summary:
Sponsor: Hospital General de Mexico

Current Primary Outcome:

  • 30 day-survival [ Time Frame: 30 days ]
  • Malondialdehyde serum levels [ Time Frame: 14 and 30 days ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • 3 month-survival [ Time Frame: 3 months ]
  • 6 month-survival [ Time Frame: 6 months ]


Original Secondary Outcome: Same as current

Information By: Hospital General de Mexico

Dates:
Date Received: June 10, 2014
Date Started: April 2010
Date Completion:
Last Updated: November 8, 2014
Last Verified: November 2014